Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphencyprone alone versus diphencyprone plus anthralin in alopecia areata
IRCT20141209020250N4Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in alopecia areata comparing Diphencyprone alone with Diphencyprone plus anthralin (2 arms). Primary endpoints: Hair regrowth rate, Change in SALT score and 3 more. Started Jul 2018; status: completed.
02
Drugs
diphencypronedithranol
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20141209020250N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020250N4.